Open access peer-reviewed chapter

Salmonella enterica Transmission and Antimicrobial Resistance Dynamics across One-Health Sector

Written By

Leonard I. Uzairue and Olufunke B. Shittu

Submitted: 08 July 2022 Reviewed: 29 November 2022 Published: 19 January 2023

DOI: 10.5772/intechopen.109229

From the Edited Volume

Salmonella - Perspectives for Low-Cost Prevention, Control and Treatment

Edited by Hongsheng Huang and Sohail Naushad

Chapter metrics overview

116 Chapter Downloads

View Full Metrics

Abstract

From human infection to animal production and the environment, Salmonella enterica has become a global-threat. The pathogen’s dynamics have been determined by its transfer from sector to sector. Antibiotic-resistant bacteria can survive and proliferate in antibiotics. Misuse of antibiotics has made certain S. enterica resistant. The One-Health sector has antibiotic-resistant Salmonella (an approach that recognizes that human health is closely connected to the health of animals and the shared environment). According to certain studies, most animal and environmental S. enterica have virulence genes needed for human infections. S. enterica antibiotic resistance patterns have varied over the decades, resulting in pan-drug-resistant-strains. Plasmid-mediated fluoroquinolone resistance genes are found in One-Health Salmonella species. The S. enterica subspecies Typhi has been found to be extensively drug-resistant (XDR) in some areas. Cephalosporin-resistant S. enterica subspecies Typhi is a severe problem that underscores the need for Vi-conjugat-vaccines. New diagnostics for resistant-Salmonella in food, animal, environment, and human sectors are needed to control the spread of these deadly infections. Also, hygiene is essential as reduced transmissions have been recorded in developed countries due to improved hygienic practices. This chapter aims to discuss the transmission and antimicrobial resistance dynamics of S. enterica across the One-Health sector.

Keywords

  • Salmonella
  • transmission
  • one-health
  • resistance
  • detection of Salmonella

1. Introduction

Antibiotic-resistant Salmonella are pathogens that antibiotics cannot control or kill. They may survive and even increase in the presence of an antibiotic. Salmonella is the causative agent of salmonellosis, an intestinal illness affecting humans and animals [1]. Salmonellosis is a fairly prevalent disease that is transmitted around the world. Salmonella is a leading agent in the development of acute and chronic diarrhea. Some species have been linked to systemic infection and sepsis that led to the deaths of various animals and humans. Salmonellosis is significant in the One-Health strategy and is consequently of major relevance to public health [2]. Recently, resistant Salmonella has been found in humans, animals, and the environment (One-Health sector) [3]. One-Health sector is a concept used to recognize the interrelation of human health, animal health, and the shared environment and how diseases and pathogens move across the three sectors. Salmonella infection has been shown to produce severe systemic illness, which is responsible for large economic losses to the commercial chicken sector due to morbidity, mortality, and decreased egg production [4, 5] as reported by the Food and Agriculture Organization (FAO). The transmission has been a subject of argument by several writers [6, 7].

The selection pressure induced by antimicrobials Salmonella is a driving factor behind the emergence and spread of resistant bacteria, including Salmonella enterica pathogens, which were genetically encoded, transmitted by successive offspring, and in some instances could be transferred horizontally to distantly related bacteria [4]. Also, employing antimicrobials in food animal husbandry has increased the emergence of resistant S. enterica from food-producing animals [8]. Antibiotic-resistant Salmonella infections have grown in recent decades, making treatment more challenging. Because antimicrobial resistance is passed from one generation of bacteria through vertical transmission, resistant bacteria, in this case S. enterica, keep striving. Antibiotic-resistant Salmonella has risen for numerous causes. Salmonella infections require new antibacterial classes [9]. Some scientists hypothesize that Salmonella antimicrobial resistance is linked to invA expression and other mechanisms by which Gram-negative bacteria develop resistance [10, 11]. Some S. enterica subspecies Typhi strains with reduced ciprofloxacin sensitivity have emerged in the Indian subcontinent, southern Asia, and sub-Saharan Africa, leading to treatment failure [9, 12, 13]. S. enterica subspecies Typhi has resistant to first-line antibiotics such as chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole [13, 14]. Ceftriaxone, cefotaxime, and cefixime are also used to treat enteric fever, including nalidixic- and fluoroquinolone-resistant forms [10, 11].

Continuous abuse regarding the overuse of fluoroquinolone and certain cephalosporins in the management of Salmonella infection is underscored by the lack of effective antimicrobial stewardship programs, which has impacted antimicrobial resistance issues. Horizontal transfer of resistance genes via genetic elements like plasmids, transposons, and integrons has also impacted antimicrobial resistance issues, rendering those previously susceptible to becoming non-susceptible. Thus, the observed resistance or reduced susceptibility of Salmonellae to fluoroquinolones and some cephalosporins could result from genetic modification due to gene transfer. The resistant genes in Salmonella are embedded in the Salmonella pathogenic islands (SPIs). Studies have identified several SPIs, particularly the presence of mobile genetic elements (MGEs), which caused the rapid spread of resistant genes due to the high transmissible MCEs from one bacterium to the other [15, 16]. S. enterica are highly associated with multiple MGEs; these MGEs are in the SPIs, which are the center of virulence of S. enterica [17]. This book chapter aims to discuss the transmission dynamic of antibiotic-resistant S. enterica across humans, environments, and animals. The chapter discusses the genus Salmonella; the host adaptability of Salmonella; the virulence determinants of Salmonella; the transmission of antibiotic-resistant S. enterica in humans, animals, and the environment; and the detection of S. enterica and its antimicrobial resistance.

Advertisement

2. The genus Salmonella

Dr. Daniel Salmon, a veterinary bacteriologist who worked for the United States Department of Agriculture (USDA), was honored by having his name bestowed on the genus Salmonella [18]. Salmonella is non-sporulating short Gram-negative bacilli [19], and most move with the help of peritrichous flagella. However, some serotypes of Salmonella, such as Salmonella pullorum and Salmonella gallinarum, are not motile [20]. They may be aerobic or facultative anaerobic, and the optimal temperature range for growth is between 5 and 45 degrees Celsius. At a temperature of 37 degrees Celsius, growth is most optimal. The optimum pH for reproduction is 7; however, Salmonella may live in environments with pH values ranging from 4 to 9 [21]. They grow in culture media designed for enterobacteriaceae and in blood agar. In addition, they grow in specialized media such as Salmonella-Shigella Agar and some ChromoAgar. Their colonies range from 2 to 4 millimeters in diameter and have smooth and round edges. They are slightly raised in a medium that contains carbon and nitrogen [22, 23]. When preserved in variable media such as peptone broth, colonies have the potential to maintain their viability for a significant amount of time [23, 24]. Salmonella strains have the biochemical capacity to catabolize nutrients, D-glucose, and other carbohydrates, except for lactose and sucrose, resulting in the generation of acid and gas [25]. Salmonella can utilize citrate as their only source of carbon, reduce nitrate to nitrite, and have the potential to produce hydrogen sulfide [19]. They are catalase positive and oxidase negative. They neither ferment malonate nor hydrolyze urea, and they do not produce indole. The bacterium has a coating of mucus around it, which helps to protect it from being digested by phagocytes, and it also has a fringe of fimbria placed around its outer surface, which helps it adhere to cells [19, 25, 26].

Salmonella is a member of the family of bacteria known as Enterobacteriaceae, which, along with other major pathogens in this group, are frequently implicated in causing illness in the small intestine. However, once the bacteria establish a foothold in the small intestine, they can move throughout the body and cause full-blown systemic disease [25]. S. enterica and Salmonella bongori are the two taxonomic species that make up the genus Salmonella. There are six subspecies of S. enterica: S. enterica subspecies enterica, S. enterica subspecies salamae (II), S. enterica subspecies arizonae (IIIa), S. enterica subspecies diarizonae (IIIb), S. enterica subspecies houtenae (IV), and S. enterica subspecies indica (VI) [25]. S. bongori and most of the subspecies of S. enterica populate the environments of cold-blooded animals, and in certain instances, S. enterica may cause sickness in these animals [27]. However, S. enterica subspecies enterica is the most biomedically significant subspecies. This is because these subspecies’ serovars have a particularly important clinical importance in both veterinary and human disorders. Based on the structures of their flagellar (H) antigens and lipopolysaccharide (LPS) (O) antigens, S. enterica subspecies enterica may be further subdivided into approximately 2500 different serovars [25, 28].

2.1 Host adaptability of S. enterica

Despite their genetic connection, Salmonella strains may be distinguished from one another by their virulence, host adaptability, and host specificity [24, 25]. There is a wealth of epidemiologic information about S. enterica subspecies serovar host specificity. Certain serovars have a preference for certain hosts but are not exclusive to those hosts. Serovars Typhi, Paratyphi A, Gallinarum, and Pullorum are only transmitted from one host to another. Serovar Typhi is responsible for causing typhoid fever in humans [13, 29], while serovar Paratyphi A causes paratyphoid in humans [30]. The serovar Pullorum is responsible for causing disease in poultry, known as systemic pullorum disease [31, 32, 33], which is associated with high mortality and intestinal inflammation [34]. In contrast, serovar Gallinarum is responsible for causing severe systemic fowl [35, 36].

Both Salmonella typhimurium and Salmonella enteritidis can infect a wide variety of animal hosts. Interestingly, they are responsible for transmitting distinct illnesses in various animal species [3, 33, 34, 35]. In humans, the serovar Dublin is sometimes known to induce septicemia and gastrointestinal illness [32, 33]. The serovar Typhimurium and, less often, Enteritidis may cause enterocolitis in calves, which can lead to death from dehydration [37]. The serovars Enteritidis and Typhimurium that cause systemic illness and diarrhea in freshly born chicks are carried by older hens, who are asymptomatic carriers [4, 38]. Serovars Enteritidis and Typhimurium induce a localized, self-limiting form of enterocolitis in humans with healthy immune systems. However, immunocompromised people are more likely to develop a systemic form of the illness [29, 39]. In mouse strains that are sensitive to the illness, serovars Enteritidis and Typhimurium may induce a systemic fever similar to typhoid, although, in other investigations, they do not cause diarrhea [36, 40, 41].

2.2 Virulence determinants of Salmonella

Salmonella displays a wide range of virulence factors that make the bacterium harmful [9, 42]. Polymorphic surface carbohydrates, an abundance of fimbrial adhesins, phase-variable flagella, and well-structured invasion and survival mechanisms in host macrophages and other cells are likely examples of these traits [43, 44]. Nearly 200 genes on the chromosomes of Salmonella are crucial for the pathogenicity of the bacterium [36]. These genes are located in the five SPI-1 to SPI-5 chromosomal pathogenicity islands. A genetic component called a pathogenicity island may also be found on the chromosome [45]. This part of the chromosome exists as a separate and distinct entity from the rest of it. All pathogenicity islands have a few traits, including the inability to be identified in closely related, nonpathogenic reference species or strains and the frequent encapsulation of substantial areas of DNA (10–200 kB), containing genes that typically impart virulence to bacteria [46, 47, 48, 49, 50, 51].

In most cases, they are also connected to elements like inverted repeats, transposases, and integrases [52]. Two of the type III secretion systems that allow Salmonella species to colonize new environments more easily are encoded by SPI-1 and SPI-2 [53]. Salmonella SPI-2 is only found in Salmonella species and is conserved across all of these species [43]. Even though SPI-2 is the sole gene unique to Salmonella, SPI-2 is necessary to establish bacterial invasion and internalization. At the same time, SPI-1 is necessary for developing systemic infection and intracellular replication [54, 55, 56, 57]. The SPI-1 protein is necessary for bacterial invasion and internalization [58]. Therefore, an SPI1 gene that is both present and functioning is required for Salmonella species to be able to cause sickness [58]. On centisome 63 of Salmonella pathogenicity island-1, a 40 kb region carries a significant portion of the genes required for intestinal penetration and invasion of host cells [58]. The Salmonella pathogenicity island-1 includes this region [59]. Environmental isolates of Salmonella that had naturally occurring deletions in the SPI-1 region were unable to enter mammalian cells, according to research by Ginocchio and associates [60]. Salmonella isolates have the potential to colonize and infiltrate intestinal epithelial cells as well as transfer pathogenic effector proteins from the bacteria into the cytosol of the host cell due to the presence of at least 37 genes in the SPI-1. Salmonella isolates may also transfer harmful effector proteins into the host cell’s cytoplasm. Numerous parts of the type III secretion systems (T3SSs) [61], as well as their regulators and secreted effectors, are encoded by these genes [62]. SPI-1 is included inside the Salmonella pathogenicity island 1. After invaders seize control of host cells, the SPI-2 genes express themselves. These genes, which are required for intracellular life, are only present in Salmonella for survival within epithelial cells and macrophages [63]. Mutants’ pathogenicity was much diminished because they could not colonize the infected individuals’ spleens and lacked SPI-2 genes [58, 63]. The effector proteins sipA, sipB, sipC, sifA, hilA, hilC, and hilD, as well as invA, spiC, and invF, are among those secreted [61]. These chromosomal clusters of virulence genes can only be found in Salmonella and are unique to those species.

2.3 Transmission of antibiotic-resistant S. enterica in humans, animals, and the environment

Antibiotic resistance mechanisms in S. enterica include resistance to aminoglycosides (e.g., alleles of aacC, aadA, aadB, ant, aphA, and StrAB), B-lactams (e.g., blaCMY-2, TEM-1, and PSE-1), chloramphenicol (e.g., floR, cmlA, and StrAB), and other antibiotics [64]. In some strains of Salmonella, multidrug resistance mechanisms were shown to be associated with integrons or mobile genetic elements (MGEs) such as IncA/C plasmids [65, 66]. Salmonella that is resistant to antibiotics may be transmitted from animals raised for food to people; in this case, there will be similarities in the resistant patterns and genes present [67]. Salmonella strains that are resistant to antibiotics have been found in humans, and some of these strains have antibiotic-resistant components that are the same as those found in Salmonella isolated from food animals [5, 68, 69]. This suggests that these strains may have come from the same source, which is an evidence of cross-transmission.

Humans are the principal reservoir for Salmonella serovars Typhi and other human-specific serovars. In contrast, other animal species are the key reservoirs for non-typhoidal Salmonella (NTS), which has been linked to human illnesses and infections in other animal species [13]. Salmonella may be found in the feces of practically every animal species; as a result, the zoonotic transmission of Salmonella is not restricted to animals raised for human consumption alone [70, 71]. Foods produced from poultry are the primary cause of Salmonella infections in humans, namely, in eggs, egg products, and chicken meat. Veterinarians and public health officials have identified the shedding of Salmonella as a source of infections for dog handlers, dog owners, and the communities in which they live [18, 22]. This suggests that pets, and particularly dogs in close contact with humans, may be responsible for the transmission of Salmonella. Infected dogs may continue to be carriers of the disease and feces shedders, making them a source of Salmonella for humans and other animals. Although these sources are not often responsible for big outbreaks, they may be responsible for isolated occurrences [70], which is why contact with ill cattle is a systematic way for farm workers to be exposed to diseases. The Centers for Disease Control and Prevention (CDC) reported several outbreaks of multidrug-resistant S. typhimurium infection associated with veterinary facilities. In areas with poor sanitation and contaminated water, fecal–oral transmission from person to person is the route for enteric or typhoid fever [71]. Salmonella typhi is only known to be carried by humans, not any other animals. S. enterica serovars, which have a wide host range, are common in the populations of warm-blooded animals that contribute to the human food supply.

Bacterial transmission typically occurs through the consumption of raw or undercooked food products [63], with poultry being one of the most important reservoirs of Salmonella species [13, 37]. Salmonella strains of many different serotypes have been identified from their natural environments and food sources around the globe [29, 72]. According to Fazl and colleagues’ research [45], hens are the primary vector for the vertical spread of Salmonella, which occurs via the ingestion of chicken eggs. Salmonella spreads quickly from breeding flocks to broiler and commercial egg-laying flocks. Salmonella spreads horizontally between birds through the fecal–oral pathway. The bacteria persist in the environment and have been isolated from poultry litter and dust [73]. The CDC reported in August 2018 about an outbreak of Salmonella Infantis from chicken products, which had also been reported previously [71, 74, 75].

Animal diseases are often brought on by ingesting contaminated food or water. To infiltrate the intestinal epithelium and colonize the mesenteric lymph nodes and other internal organs in the case of a systemic infection. Salmonella bacteria must withstand the challenging circumstances of the digestive tract [67]. Both humans and animals may get Salmonella infections when exposed. The ability of Salmonella to link with host cells and trigger its internalization has been studied [13]. These are essential for Salmonella to survive in the host environment and enter non-phagocytic cells. Animal waste commonly allows Salmonella to enter agricultural environments [76]. Plants and surface water used for irrigation or as a diluent for pesticides or fertilizers may be directly contaminated by animal feces [77]. There has been an increase in recent years in the number of reports that show a link between foodborne disease and the eating of fresh produce contaminated with Salmonella [78]. Salmonella can adapt to various environmental conditions, including those with a low pH or high temperature, allowing it to survive outside the host organism. Salmonella may adhere to plant surfaces and attach before actively infecting a variety of plant interiors. Salmonella that originates in plants retains its virulence when infecting animals [79]. Plants may thus act as a secondary host for Salmonella infections and contribute to spreading the bacteria to animals and humans.

2.4 Antimicrobial resistance of S. enterica from humans, animals, and the environment

The mechanisms of antibiotic resistance fall into three categories: (1) inactivation of the antimicrobial, (2) efflux or changes in permeability or transport of the resistance pathogen, or (3) modification or replacement of the antimicrobial target [80, 81]. Resistance is genetically encoded and may result from mutations in endogenous genes, horizontal gene transfer via plasmids, or horizontal acquisition of alien resistance genes [81, 82]. Both horizontally acquired genes and point mutations may contribute to resistance encoding. Promoter or operator point mutations might be the root cause of overexpression of endogenous genes like the AmpC-lactamase gene or the mar locus [83]. Some antimicrobial target genes, like the gyrase gene, are susceptible to point mutations that may turn them into resistant targets. Exogenous resistance genes encoded on plasmids, integrons, phage, and transposons can be horizontally propagated via the processes of transformation, conjugation, and transduction [84]. This includes genes that code for enzymes that render the antimicrobial inactive, such as lactamases that cleave the four-membered ring in lactams; efflux systems, such as tet (A); altered versions of the enzymes the antimicrobial is intended to inhibit, such as dfrA; or enzymes that alter the antimicrobial target, such as ribosomal RNA methylase [85, 86, 87].

Additionally, by researching the mechanisms of resistance, one may discover the genetic link between animal and human resistance [88, 89]. Suppose the antibiotic resistances seen in human bacterial isolates are closely related to those seen in animal isolates. In that case, it may be possible to identify animal sources of resistant bacteria in human infections that can be targeted to reduce human disease [76, 90, 91]. This can be done by determining if the resistances seen in human bacterial isolates are similar to those seen in animal isolates [92]. This is possible due to the diversity of genetic factors contributing to antibiotic resistance.

Antibiotic resistance among Salmonella strains is increasing, which is a major cause for worry in protecting public health worldwide [93]. At the beginning of the 1960s, it was revealed that Salmonella had first developed resistance to a single antibiotic [88]. Since then, more Salmonella strains resistant to one or more antimicrobial medications have been isolated in various countries, including developed nations [94]. This trend has been seen in several countries. Traditional antibiotic therapies for Salmonella infections include penicillin, chloramphenicol, and trimethoprim-sulfamethoxazole, which are just a few available options. These treatments are believed to be the earliest lines of defense against Salmonella. Salmonella strains resistant to many antibiotics are referred to as multidrug-resistant Salmonella. The MDR phenotypic characteristic was extensively dispersed throughout S. enterica over an extended time, particularly in S. typhi and, to a lesser degree, in Salmonella paratyphi [68, 95]. Asia and Africa are two continents with a substantial incidence of S. enterica strains with the MDR feature [96]. During a surveillance investigation carried out in several nations in Asia and Africa, a significant number of S. enterica MDR isolates were identified [97]. The research particularly pointed to Pakistan, India, Nepal, and Vietnam, where extensive drug-resistant Salmonella was discovered. Because of the widespread use of fluoroquinolones and extended-spectrum cephalosporins, which were used to treat MDR S. enterica, there has been an increase in S. enterica that are capable of producing beta-lactamases [17, 98]. This is because traditional antibiotics have become less effective due to the widespread use of drugs like fluoroquinolones and extended-spectrum cephalosporins. Despite this, some evidence suggests that an increasing number of typhoid Salmonella are acquiring resistance to fluoroquinolones. Isolates from various nations have been reported to be resistant to nalidixic acid, which suggests that they have diminished sensitivity to ciprofloxacin and other fluoroquinolones [93, 99]. The rise in resistant non-typhoidal Salmonella (NTS), particularly in animals used in food production, has made controlling the spread of S. enterica strains resistant to antibiotics more difficult. This is true in particular for animals that are reared for their meat. According to the investigation findings, the MDR phenotype was present in most NTS clinical isolates. Public health officers have voiced their worries over treating ailment and prevention due to this phenomenon.

The use of antibiotics in animal feed to stimulate the development of food animals and in veterinary care to treat bacterial illnesses in those animals is the primary factor that contributes to the establishment of Salmonella with antimicrobial resistance [67]. This is a high risk of zoonotic illness due to the transfer of MDR Salmonella strains from animals to people via the intake of food or water contaminated with the feces of the animals, through direct contact or by the consumption of diseased food animals. Additionally, multidrug-resistant Salmonella strains were discovered in the aquatic habitat of some exotic pet animals, such as tortoises and turtles [100]. This might lead to an increased risk of zoonotic infections in people via direct contact with these animals [74, 76, 90].

2.5 Detection of S. enterica and its antimicrobial resistance

Several methods are used to detect Salmonella and its resistance patterns and genes. There are conventional or culture, serological, and molecular techniques, including polymerase chain reaction and sequencing. Confirming infection with Salmonella is required before treatment [101, 102, 103]. A diagnosis may be confirmed by culture and isolation. Salmonella isolates may be differentiated in various ways, and the number of Salmonella species is continually expanding [104, 105]. Salmonella is typed using complex procedures in addition to serotyping based on antigens to track individual isolates and explain pathogenicity [58, 86]. It is essential from an epidemiological standpoint to distinguish Salmonella isolates because definitive typing may assist in locating the source of an epidemic and tracking changes in antibiotic resistance [105].

Pre-enrichment, selective enrichment and culturing, isolation, biochemical characterization, serological characterization, and final identification are the steps that are included in the standard approach for detecting Salmonella [106, 107]. This method needs at least 4 days to get a negative result, and it takes between six and 7 days to identify and confirm positive samples.

Antibiotic sensitivity testing (AST) measured by inhibition zones is determined by the disk diffusion method, and it is proportional to the susceptibility of the bacteria to the antibiotic on the disk [108]. This depends on the antibiotic disk’s potency and infusing ability. It may not take much modification to use disk diffusion for testing antimicrobial disks [109]. It is used to screen many isolates to choose a subset for further testing, such as MIC determinations. Antimicrobial types must include interpretation criteria (susceptible, intermediate, and resistant) based on standards, guidelines, and quality control reference organisms. Approaches to AST are selected based on their user-friendliness, versatility, adaptability to automated or semi-automated systems, cost-effectiveness, dependability, and accuracy. Conventional Salmonella serotyping is most typically done [110].

S. enterica serotyping is conducted on a global scale, which has enabled improvements in the monitoring and detection outbreaks on a global scale. The O (somatic), H (flagellar), and Vi (capsular) antigens from the lipopolysaccharide (LPS) layer of the cell wall are used for serotyping Salmonella isolates [111, 112]. Salmonella may spontaneously and reversibly change between these two stages of flagellar antigen synthesis, each containing a unique set of H antigens. This phenomenon is known as diphasic flagellar antigen production. In the first phase, also known as the specific phase, the various antigens are denoted by lowercase letters; in the second phase, also known as the group phase, the antigens found initially are given numbers [113, 114]. Traditional serotyping, which uses the autoagglutination method, has some important drawbacks. One is the inability to identify non-typeable Vi antigens and strains [75, 115]. It takes a lot of time, a lot of different chemicals, and a lot of experienced laboratory workers to do this [4].

Latex agglutination, enzyme immunoassay (EIA), and enzyme-linked immunosorbent assay (ELISA) are three examples of the types of immunological tests that have been developed to identify and confirm Salmonella [29, 39, 98] quickly.

DNA hybridization and PCR are two more methods that may be used to identify S. enterica [116, 117]. Amplification and analysis of strain variation may be accomplished by using gene-specific primers in PCR testing. It can improve the detection and characterization of pathogenic bacteria by targeting species-specific DNA regions and specific pathogenicity traits, such as genes that code for toxins, virulence factors, or major antigens [84, 118, 119]. This makes it possible for it to improve the detection of pathogenic bacteria. Other Salmonella strain typing methods include utilizing antibiotic resistance genes as epidemiological markers using multilocus sequence typing [5, 7, 111].

These methods examine the DNA sequences of a series of housekeeping, ribosomal, and virulent genes, and therefore making isolates distinction based on the molecular analysis. This uses short sequence repeat motifs as a target to type isolates.

The polymerase chain reaction (PCR) and real-time PCR are being investigated as potential diagnostic tools for enteric fever [112]. In theory, nucleic acid amplification tests (NAATs) might amplify DNA from bacteria that are either dead or incapable of being cultured, hence rectifying low culture positives caused by antibiotic pre-treatment [113]. According to research [114], the test sensitivity limitations for a PCR technique are the same as those for a culture approach. Culture and PCR are combined in some methodologies. The adoption of NAATs in developing countries is expected to be hampered because of the high cost and lack of laboratory infrastructure [120]. The effectiveness of NAATs for the diagnosis of enteric fever has been the subject of some research. The flagellin genes (fliC-d for S. Typhi and fliC-a for S. Paratyphi A) are most often targeted by PCR [121, 122]. In a study of blood PCR testing for enteric fever, researchers found that although all tests were 100 percent specific, their sensitivities differed [83, 123]. The sensitivity is considerable in most studies to be more than 90% [20] in persons with positive blood culture, but it is lower (3–13%) in those without clinical symptoms [14].

Additionally, PCR tests focusing on fliC have been applied to urine, and the findings have been favorable [124]. The primary benefit of PCR over other identification methods, like culture and conventional methods, is that it produces findings much more quickly [124]. PCR requires specialist laboratory equipment, which might be difficult in regions where typhoid fever is prevalent [14, 39]. Whole-genome sequencing (WGS) has revolutionized how antimicrobial resistance is studied [125, 126]. It has enabled the detection of resistance genes even before they are expressed and has also played a very important role in epidemiological studies of antimicrobial resistance Salmonella [127]. These techniques have helped develop newer diagnostics and are being explored in vaccine candidate development for several Salmonella species other than Typhi [128].

Both phenotypic and genotypic methods detect resistance genes or resistance mechanisms in bacteria, specifically in S. enterica [17]. The phenotypic method explores this bacteria’s expression of certain traits to detect a resistance mechanism [122]. For example, the resistance by Salmonella to third-generation cephalosporin is an indication of possible possession of extended-spectrum beta-lactamases (ESBLs) [129]. Salmonella resistance to Meropenem is an indication to been carbapenemase-producing [130]. Genotypic techniques are employed to confirm the phenotypic detection of an antibiotic-resistance mechanism [131]. Some of these genotypic methods for antibiotic resistance genes include whole genome sequencing and polymerase chain reaction application. Whole genome sequencing is expensive, and as such, it is not routinely used to detect resistance genes. Polymerase chain reaction (PCR) is the method of choice for laboratories with the capacity [132]. Quantitative and conventional PCR is used. Quantitative PCR uses specific primers and probes to detect the resistance or virulence gene of interest. Conventional PCR, which is mostly available and more cost-effective, uses specific primers, and the products are visualized in a gel documentation system after amplification [133].

2.6 Prevention and control of resistant antibiotics and virulent S. enterica across one-health sectors

The prevention of S. enterica infection involves proper co-ordination of preventive measures across the humans and their activities, that is, agriculture, animal rearing for food, the use of animals as companions or pets, and management of environment sector to detect and eliminate any threat [100, 134] of Salmonella [100, 134]. The different levels of prevention of S. enterica pathogens include: prevention of S. enterica pathogens from farms to human via food or through the contaminated environment via poor waste management [120, 135]. The proper management of farms to eliminate pathogenic bacteria from the animal facilities is one effective way of managing Salmonella outbreaks. Also, prosper handling of food processing and animal products contributed to reduced outbreaks [10, 136]. Some keys Salmonella infection outbreaks were associated with transmission from processed food animals like chickens, pork, and other meat products. The use of animal wastes as fertilizers has also been associated with S. enterica outbreaks [76]. Full implementation of good hygiene practices across all sectors, including house hygiene practices and deployment of WASH in all sectors, will eliminate S. enterica from the food chain and all possible transmission avenues.

By consuming contaminated food or drink, enteric fever is most often spread from person to person [134]. In the past, enteric fever was common in Western Europe and the United States [75]. Despite this, pasteurization of milk and other dairy products, the removal of human feces in the food-manufacturing process, and good food and water cleanliness have all contributed to a considerable decline in the prevalence of Salmonella infection [137]. There was a decrease in the number of Salmonella illnesses reported in Latin America simultaneously as sanitary techniques were implemented [137]. Giving access to clean water and food, maintaining proper sanitation, and administering typhoid vaccinations are the best ways to avoid enteric fever. Making and ensuring that water meant for human consumption is safe is the main goal of eliminating possible vectors for the transmission of typhoid Salmonella and non-typhoid Salmonella (NTS). This important objective has been easily achieved in wealthy nations like Europe and the United States but not in developing or underdeveloped countries [138]. In addition to water, a variety of foods may include Salmonella species. However, they are often found in poultry, eggs, and dairy products [139]. The adoption of proper food handling and cooking practices has been proposed to prevent bacterial contamination of food. Due to its efficacy in reducing the risk of food contamination, food irradiation has attracted considerable interest and support in several countries. Several public health agencies, including the WHO and the CDC, have approved irradiating food. Still, due to the risk posed by radioactivity, it is only partially used in certain parts of Europe and the United States [103]. Vaccination is one of the best methods to protect against enteric fever [140]. The inactive parenteral and oral live attenuated vaccines are the two immunization types that may presently be utilized to prevent enteric fever. However, these authorized immunizations are exclusively used in infants and are ineffective at preventing diseases by S. enterica subspecies Paratyphi and NTS. Limiting the erroneous use of antibiotics in food animals and the feed they ingest is one approach that is good for NTS.

Hazard analysis and critical control points (HACCP) are advantageous since it is an efficient strategy for minimizing risk and maximizing product security [141]. The HACCP is employed at various stages of the One-Health sector. This is important to avoid cross-contamination or transfer of pathogenic S. enterica from the environment to processed food, humans, and vice versa. One way of implementing HACCP in the animal sector is to ensure that Salmonella pathogens are not released into the environment [142]. And everyone involved in the processing steps of food are tested for S. enterica to avoid shedding in processed food [143]. Implementing HACCP has several advantages, including eliminating prejudice and providing a framework for prioritizing choices. HACCP helps ensure that only those with the necessary knowledge, skills, and experience are responsible for food safety. With HACCP in place, there is concrete proof of your food safety management, which will be useful in court in the case of any litigation. After the initial investment in implementing HACCP, the system may be very cost-efficient. As a result of HACCP, food manufacturers may fulfill their mandated duty to create healthy, wholesome fares in compliance with applicable regulations [144]. Applying HACCP’s procedures and guidelines almost guarantees better results every time. This is mostly attributable to people’s heightened sensitivity to risks and the fact that they come from all walks of the operation. The HACCP principles and the requisite support mechanisms for a robust food safety program form the basis of the Global Food Safety Initiative (GFSI) by ensuring the absence of Salmonella pathogens in processed food, poultry farms, and the food chain [142, 145].

Advertisement

3. Conclusion

The distribution of Salmonella subspecies capable of causing infections has been found in humans, animals, and environments. Salmonella genes such as sipA, sipB, sipC, sifA, hilA, hilC, hilD, as well as invA, spiC, and invF have been linked to epidemiologic of virulent S. enterica. Some of the Salmonella from all these sources tested positive for the beta-lactamase TEM enzyme. To detect S. enterica, invA has been found valuable in detecting S. enterica contamination in food products and the environment. The invA gene has been made into devices and diagnostics for diagnosing infections in the bloodstream, environmental contamination, and water-processing plants. These factors have also been utilized in investigating outbreaks and infection tracing and tracking, especially in food-processing industries. The detection of this genes even without viable growth of S. enterica has helped control and contain outbreaks. Genes for resistance to fluoroquinolones mediated by plasmids has also been widely found in Salmonella species across the One-Health sector. According to research findings, most Salmonellae are obtained from animals, and the environment carries the virulence genes essential to induce infections in humans. Extensively drug-resistant (XDR) Salmonella typhi is now a serious problem in some countries, multidrug-resistant (MDR) has grown in prevalence, and S. enterica has evolved resistance to an increasing number of antibiotic classes. Extensively drug-resistant (XDR) S. typhi, so designated due to its exhibited resistance to the recommended drugs for typhoid fever, including third-generation cephalosporin, has become a serious issue that highlights the urgency in deploying the Vi-conjugate vaccines.

Advertisement

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1. Kiran Y, Yadav SK, Geeta P. A comparative study of typhidot and widal test for rapid diagnosis of typhoid fever. International Journal of Current Microbiology and Applied Sciences. 2015;4:34-38
  2. 2. WHO. Salmonella (non-typhoidal). Vol. 1. Geneva: WHO; 2017
  3. 3. Trinh P, Zaneveld JR, Safranek S, et al. One health relationships between Human, animal, and environmental microbiomes: A mini-review. Frontiers in Public Health. 2018;6:1-9
  4. 4. Fadlallah SM, Shehab M, Cheaito K, et al. Molecular epidemiology and antimicrobial resistance of Salmonella species from clinical specimens and food items in Lebanon. Journal of Infection in Developing Countries. 2017;11:19-27. DOI: 10.3855/jidc.7786
  5. 5. Kristinsson KG, Georgsson F. Infection risks associated with importation of fresh food in Iceland. Læknablađiđ. 2015;101:313-319
  6. 6. Feasey NA, Masesa C, Jassi C, et al. Three epidemics of invasive multidrug-resistant Salmonella bloodstream infection in Blantyre, Malawi, 1998-2014. Clinical Infectious Diseases. 2015;61:S363-S371
  7. 7. Andrews JR, Ryan ET. Diagnostics for invasive Salmonella infections: Current challenges and future directions. (special issue: Global progress on use of vaccines for invasive Salmonella infections.). Vaccine. 2015;33:C8-C15
  8. 8. Irwin Alec, Berthe Franck Cesar Jean, Le Gall Francois G., Marquez PV. Drug-resistant infections: A threat to our economic future: Executive summary (English). 2017;2:1-17
  9. 9. Nógrády N, Imre A, Kostyák Á, et al. Molecular and pathogenic characterization of Salmonella enterica Serovar Bovismorbificans strains of animal, environmental, food, and Human origin in Hungary. Foodborne Pathogens and Disease. 2010;7:507-513
  10. 10. Banerjee S, Ooi MC, Shariff M, et al. Antibiotic resistant Salmonella and Vibrio associated with farmed Litopenaeus vannamei. Scientific World Journal. 2012;2012:130136
  11. 11. Gharieb RM, Tartor YH, Khedr MHE. Non-Typhoidal Salmonella in poultry meat and diarrhoeic patients: Prevalence, antibiogram, virulotyping, molecular detection and sequencing of class I integrons in multidrug resistant strains. Gut Pathogens. 2015;7:34. DOI: 10.1186/s13099-015-0081-1
  12. 12. Chen W, Fang T, Zhou X, et al. IncHI2 plasmids are predominant in antibiotic-resistant Salmonella isolates. Frontiers in Microbiology. 2016;7:1566. DOI: 10.3389/fmicb.2016.01566
  13. 13. Obaro SK, Hassan-Hanga F, Olateju EK, et al. Salmonella bacteremia among children in central and Northwest Nigeria, 2008-2015. Clinical Infectious Diseases. 2015;61:S325-S331
  14. 14. Crump JA, Sjölund-Karlsson M, Gordon MA, et al. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clinical Microbiology Reviews. 2015;28:901-937
  15. 15. Deng Y, Bao X, Ji L, et al. Resistance integrons: Class 1, 2 and 3 integrons. Annals of Clinical Microbiology and Antimicrobials. 2015;14:45. DOI: 10.1186/s12941-015-0100-6
  16. 16. Wellington EMH, Boxall ABA, Cross P, et al. The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. The Lancet Infectious Diseases. 2013;13:155-165
  17. 17. Ramachandran A, Shanthi M, Sekar U. Detection of blaCTX-M extended spectrum betalactamase producing Salmonella enterica serotype typhi in a tertiary care Centre. Journal of Clinical Diagnostic Research. 2017;11:DC21-DC24
  18. 18. Salisbury AM, Bronowski C, Wigley P. Salmonella virchow isolates from human and avian origins in England: Molecular characterization and infection of epithelial cells and poultry. Journal of Applied Microbiology. 2011;111:1505-1514
  19. 19. Matias CAR, Pereira IA, De Araújo MDS, et al. Characteristics of Salmonella spp. isolated from wild birds confiscated in illegal trade markets, Rio de Janeiro, Brazil. BioMed Research International. 2016;2016:3416864. DOI: 10.1155/2016/3416864
  20. 20. Kariuki S, Gordon MA, Feasey N, et al. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 2015;33:S21-S29
  21. 21. Bailey A, Scott B. Diagnostic Microbiology. Eleventh ed. London, UK: Oxford University Press (OUP); 2002
  22. 22. Geraldine MM, Raúl RA, Ana CO, et al. Identification of Salmonella enteritidis and Salmonella typhimurium in Guinea pigs by the multiplex PCR. Rev Investig Vet del Peru. 2017;28:411-417. DOI: 10.15381/rivep.v28i2.13074
  23. 23. Dongol S, Thompson CN, Clare S, et al. The microbiological and clinical characteristics of invasive Salmonella in gallbladders from cholecystectomy patients in Kathmandu, Nepal. PLoS One. 2012;7:e47342. DOI: 10.1371/journal.pone.0047342
  24. 24. Nga TVT, Karkey A, Dongol S, et al. The sensitivity of real-time PCR amplification targeting invasive Salmonella serovars in biological specimens. BMC Infectious Diseases. 2010;10:125. DOI: 10.1186/1471-2334-10-125
  25. 25. Santos RL, Mikoleit ML, Unit S, et al. Characterization of Salmonella isolates from retail foods based on serotyping, pulse field gel electrophoresis, antibiotic resistance and other phenotypic properties. Applied and Environmental Microbiology. 2014;77:187-219
  26. 26. Venkatesan N, Krishnakumar S, Deepa PR, et al. Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells. Molecular Vision. 2012;18:2420-2437
  27. 27. Berhane A, Russom M, Bahta I, et al. Rapid diagnostic tests failing to detect plasmodium falciparum infections in Eritrea: An investigation of reported false negative RDT results. Malaria Journal. 2017;16:105. DOI: 10.1186/s12936-017-1752-9
  28. 28. Boyd DA, Shi X, Hu QH, et al. Salmonella genomic island 1 (SGI1), variant SGI1-I, and new variant SGI1-O in Proteus mirabilis clinical and food isolates from China. Antimicrobial Agents and Chemotherapy. 2008;52:340-344
  29. 29. Felgner J, Jain A, Nakajima R, et al. Development of ELISAs for diagnosis of acute typhoid fever in Nigerian children. PLoS Neglected Tropical Diseases. 2017;11:e0005679. DOI: 10.1371/journal.pntd.0005679
  30. 30. Andrews JR, Ryan ET. Diagnostics for invasive Salmonella infections: Current challenges and future directions. Vaccine. 2015;33:C8-C15
  31. 31. Li Q , Hu Y, Chen J, et al. Identification of Salmonella entericaserovar Pullorum antigenic determinants expressed in vivo. Infection and Immunity. 2013;81:119-127. DOI: 10.1128/IAI.00145-13
  32. 32. Wilson RL, Elthon J, Clegg S, et al. Salmonella enterica serovars gallinarum and pullorum expressing Salmonella enterica serovar typhimurium type 1 fimbriae exhibit increased invasiveness for mammalian cells. Infection and Immunity. 2000;68:4782-4785. DOI: 10.1128/IAI.68.8.4782-4785.2000
  33. 33. Wigley P, Berchieri AJ, Page KL, et al. Salmonella enterica serovar pullorum persists in splenic macrophages and in the reproductive tract during persistent, disease-free carriage in chickens. Infection and Immunity. 2001;69:7873-7879. DOI: 10.1128/IAI.69.12.7873-7879.2001
  34. 34. Rodriguez J, Nonaka D, Kuhn E, et al. Combined high-grade basal cell carcinoma and malignant melanoma of the skin (“malignant basomelanocytic tumor”): Report of two cases and review of the literature. The American Journal of Dermatopathology. 2005;27:314-318
  35. 35. Tennant SM, Diallo S, Levy H, et al. Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali. PLoS Neglected Tropical Diseases. 2010;4:e621. DOI: 10.1371/journal.pntd.0000621
  36. 36. Suez J, Porwollik S, Dagan A, et al. Virulence gene profiling and pathogenicity characterization of non-Typhoidal Salmonella accounted for invasive disease in humans. PLoS One. 2013;8:e58449. DOI: 10.1371/journal.pone.0058449
  37. 37. Tennant SM, MacLennan CA, Simon R, et al. Nontyphoidal Salmonella disease: Current status of vaccine research and development. Vaccine. 2016;34:2907-2910. DOI: 10.1016/j.vaccine.2016.03.072
  38. 38. Sangal V, Harbottle H, Mazzoni CJ, et al. Evolution and population structure of Salmonella enterica serovar Newport. Journal of Bacteriology. 2010;192:6465-6476. DOI: 10.1128/JB.00969-10
  39. 39. Okoro CK, Kingsley RA, Connor TR, et al. Intracontinental spread of human invasive Salmonella typhimurium pathovariants in sub-Saharan Africa. Nature Genetics. 2012;44:1215-1221
  40. 40. Feasey NA, Dougan G, Kingsley RA, et al. Invasive non-typhoidal Salmonella disease: An emerging and neglected tropical disease in Africa. Lancet. 2012;379:2489-2499
  41. 41. Marks F, von Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Heal. 2017;5:e310-e323
  42. 42. Ben Hassena A, Barkallah M, Fendri I, et al. Real time PCR gene profiling and detection of Salmonella using a novel target: The siiA gene. Journal of Microbiological Methods. 2015;109:9-15. DOI: 10.1016/j.mimet.2014.11.018
  43. 43. Rao S, Schieber AMP, O’Connor CP, et al. Pathogen-mediated inhibition of anorexia promotes host survival and transmission. Cell. 2017;168:503-516. DOI: 10.1016/j.cell.2017.01.006
  44. 44. Shippy DC, Eakley NM, Bochsler PN, et al. Biological and virulence characteristics of Salmonella enterica serovar Typhimurium following deletion of glucose-inhibited division (gidA) gene. Microbial Pathogenesis. 2011;50:303-313
  45. 45. Fazl AA, Salehi TZ, Jamshidian M, et al. Molecular detection of invA, ssaP, sseC and pipB genes in Salmonella typhimurium isolated from human and poultry in Iran. African Journal of Microbiological Research. 2013;7:1104-1108
  46. 46. McWhorter AR, Chousalkar KK. Comparative phenotypic and genotypic virulence of Salmonella strains isolated from Australian layer farms. Frontiers in Microbiology. 2015;6:1-14
  47. 47. Velge P, Wiedemann A, Rosselin M, et al. Multiplicity of Salmonella entry mechanisms, a new paradigm for Salmonella pathogenesis. Microbiology. 2012;1:243-258. DOI: 10.1002/mbo3.28
  48. 48. Antonio Ibarra J, Knodler LA, Sturdevant DE, et al. Induction of Salmonella pathogenicity island 1 under different growth conditions can affect Salmonella-host cell interactions in vitro. Microbiology. 2010;156:1120-1133
  49. 49. Khoo CH, Cheah YK, Lee LH, et al. Virulotyping of Salmonella enterica subsp. enterica isolated from indigenous vegetables and poultry meat in Malaysia using multiplex-PCR. Antonie van Leeuwenhoek. International Journal of Genetics & Molecular Microbiology. 2009;96:441-457
  50. 50. Lawley TD, Bouley DM, Hoy YE, et al. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infection and Immunity. 2008;76:403-416. DOI: 10.1128/IAI.01189-07
  51. 51. Hensel M. Evolution of pathogenicity islands of Salmonella enterica. International Journal of Medical Microbiology. 2004;294:95-102. DOI: 10.1016/j.ijmm.2004.06.025
  52. 52. Izumiya H, Kuroda M, Tamamura Y, et al. Phylogenetic characterization of Salmonella enterica serovar Typhimurium and its monophasic variant isolated from food animals in Japan revealed replacement of major epidemic clones in the last 4 decades. Journal of Clinical Microbiology. 2018;56:e01758-e01717. DOI: 10.1128/jcm.01758-17
  53. 53. Li C, Hu D, Xue W, et al. Treatment outcome of combined continuous Venovenous hemofiltration and Hemoperfusion in acute Paraquat poisoning: A prospective controlled trial. Critical Care Medicine. 2018;46:100-107. DOI: 10.1097/CCM.0000000000002826
  54. 54. Walthers D, Carroll RK, Navarre WW, et al. The response regulator SsrB activates expression of diverse Salmonella pathogenicity island 2 promoters and counters silencing by the nucleoid-associated protein H-NS. Molecular Microbiology. 2007;65:477-493. DOI: 10.1111/j.1365-2958.2007.05800.x
  55. 55. Forest CG, Ferraro E, Sabbagh SC, et al. Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2. Microbiology. 2010;156:3689-3698. DOI: 10.1099/mic.0.041624-0
  56. 56. Haneda T, Ishii Y, Shimizu H, et al. Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection. Cellular Microbiology. 2012;14:485-499. DOI: 10.1111/j.1462-5822.2011.01733.x
  57. 57. Kaur J, Jain SK. Role of antigens and virulence factors of Salmonella enterica serovar Typhi in its pathogenesis. Microbiological Research. 2012;167:199-210. DOI: 10.1016/j.micres.2011.08.001
  58. 58. Huehn S, La Ragione RM, Anjum M, et al. Virulotyping and antimicrobial resistance typing of Salmonella entericaserovars relevant to human health in Europe. Foodborne Pathogens and Disease. 2010;7:523-535
  59. 59. Cao J, Xu L, Yuan M, et al. TaqMan probe real-time PCR detection of foodborne Salmonella enterica and its six Serovars. International Journal of Current Microbiology and Applied Sciences. 2013;2:1-12
  60. 60. Ginocchio CC, Rahn K, Clarke RC, et al. Naturally occurring deletions in the centisome 63 pathogenicity island of environmental isolates of Salmonella spp. Infection and Immunity. 1997;65:1267-1272
  61. 61. Malorny B, Fach P, Bunge C, Martin A, REP H, Malorny B, et al. Diagnostic real-time PCR for detection of Salmonella in food. Applied and Environmental Microbiology. 2004;70:7046-7052
  62. 62. Ulaya WD. Determination of Virulence Factors in Salmonella Isolates of Human, Poultry and Dog Origin in Lusaka District. Lusaka, Zambia: Zambia School of Veterinary Medicine, Department of Paraclinical Studies; 2013;2(3):23-32
  63. 63. Ghanizadeh A. Malondialdehyde, Bcl-2, superoxide dismutase and glutathione peroxidase may mediate the association of sonic hedgehog protein and oxidative stress in autism. Neurochemical Research. 2012;37:899-901
  64. 64. Ball TA, Fedorka-Cray PJ, Horovitz J, et al. Molecular characterization of Salmonella spp. from cattle and chicken farms in Uganda. Online Journal of Public Health Informatics. 2018. DOI: 10.5210/ojphi.v10i1.8934
  65. 65. Douard G, Praud K, Cloeckaert A, et al. The Salmonella genomic island 1 is specifically mobilized in trans by the IncA/C multidrug resistance plasmid family. PLoS One. 2010;5. DOI: 10.1371/journal.pone.0015302
  66. 66. Huguet KT, Gonnet M, Doublet B, et al. A toxin antitoxin system promotes the maintenance of the IncA/C-mobilizable Salmonella Genomic Island 1. Scientific Reports. 2016;6. DOI: 10.1038/srep32285
  67. 67. Shah M, Kathiiko C, Wada A, et al. Prevalence, seasonal variation, and antibiotic resistance pattern of enteric bacterial pathogens among hospitalized diarrheic children in suburban regions of Central Kenya. Tropical Medical Health. 2016. DOI: 10.1186/s41182-016-0038-1
  68. 68. Jajere SM. A review of Salmonella enterica with particular focus on the pathogenicity and virulence factors, host specificity and antimicrobial resistance including multidrug resistance. Veterinary World. 2019;12:504
  69. 69. Hall RM. Salmonella genomic islands and antibiotic resistance in Salmonella enterica. Future Microbiology. 2010. DOI: 10.2217/fmb.10.122
  70. 70. Osaili TM, Abu Jamous DO, Obeidat BA, et al. Food safety knowledge among food workers in restaurants in Jordan. Food Control. 2013. DOI: 10.1016/j.foodcont.2012.09.037
  71. 71. Centers for Disease Control and Prevention (CDC). Notes from the field: Human Salmonella infantis infections linked to dry dog food--United States and Canada. MMWR. Morbidity and Mortality Weekly Report. 2012;2012
  72. 72. Obaro S, Lawson L, Essen U, et al. Community acquired bacteremia in young children from Central Nigeria--a pilot study. BMC Infectious Diseases. 2011;11:137
  73. 73. Kasturi KN, Drgon T. Real-time PCR method for detection of Salmonellaspp. in environmental samples. Applied and Environmental Microbiology. 2017;83:1-12
  74. 74. Miller T, Brockmann S, Spackova M, et al. Recurring outbreaks caused by the same Salmonella infantis clone in a German rehabilitation oncology clinic over at least 2002 to 2009. The Journal of Hospital Infection. 2018. DOI: 10.1016/j.jhin.2018.03.035
  75. 75. Basler C, Forshey TM, Machesky K, et al. Notes from the field: Multistate outbreak of human Salmonella infections linked to live poultry from a mail-order hatchery in Ohio--February-October 2014. MMWR. Morbidity and Mortality Weekly Report. 2015;32:20-28
  76. 76. Shittu OB, Uzairue LI, Ojo OE, et al. Antimicrobial resistance and virulence genes in Salmonella enterica serovars isolated from droppings of layer chicken in two farms in Nigeria. Journal of Applied Microbiology. 2022;132:3891-3906
  77. 77. Stanaway JD, Parisi A, Sarkar K, et al. The global burden of non-typhoidal Salmonella invasive disease: A systematic analysis for the global burden of disease study 2017. The Lancet Infectious Diseases. 2019;19:1312-1324
  78. 78. Gopinath S, Carden S, Monack D. Shedding light on Salmonella carriers. Trends in Microbiology. 2012. DOI: 10.1016/j.tim.2012.04.004
  79. 79. Berger CN, Sodha SV, Shaw RK, et al. Fresh fruit and vegetables as vehicles for the transmission of human pathogens. Environmental Microbiology. 2010. DOI: 10.1111/j.1462-2920.2010.02297.x
  80. 80. Rawat D, Nair D. Extended-spectrum ß-lactamases in gram negative bacteria. Journal of Global Infectious Diseases. 2010. DOI: 10.4103/0974-777x.68531
  81. 81. Hawkey PM, Jones AM. The changing epidemiology of resistance. The Journal of Antimicrobial Chemotherapy. 2009. DOI: 10.1093/jac/dkp256
  82. 82. Pal C, Bengtsson-Palme J, Kristiansson E, et al. Co-occurrence of resistance genes to antibiotics, biocides and metals reveals novel insights into their co-selection potential. BMC Genomics. 2015. DOI: 10.1186/s12864-015-2153-5
  83. 83. Kariuki S, Gordon MA, Feasey N, et al. Antimicrobial resistance and management of invasive Salmonella disease HHS public access. Vaccine. 2015;19:21-29
  84. 84. Vo ATT, van Duijkeren E, Fluit AC, et al. A novel Salmonella genomic island 1 and rare integron types in Salmonella typhimurium isolates from horses in the Netherlands. The Journal of Antimicrobial Chemotherapy. 2007;59:594-599
  85. 85. Adesiji YO, Deekshit VK, Karunasagar I. Antimicrobial-resistant genes associated with Salmonella spp. isolated from human, poultry, and seafood sources. Food Science & Nutrition. 2014. DOI: 10.1002/fsn3.119
  86. 86. Flórez AB, Alegría Á, Rossi F, et al. Molecular identification and quantification of tetracycline and erythromycin resistance genes in Spanish and Italian retail cheeses. BioMed Research International. 2014;2014:1-10
  87. 87. Guerra B, Soto S, Helmuth R, et al. Characterization of a self-transferable plasmid from Salmonella enterica serotype typhimurium clinical isolates carrying two integron-borne gene cassettes together with virulence and drug resistance genes. Antimicrobial Agents and Chemotherapy. 2002. DOI: 10.1128/AAC.46.9.2977-2981.2002
  88. 88. Tran-Dien A, Le Hello S, Bouchier C, et al. Early transmissible ampicillin resistance in zoonotic Salmonella enterica serotype Typhimurium in the late 1950s: A retrospective, whole-genome sequencing study. The Lancet Infectious Diseases. 2018. DOI: 10.1016/S1473-3099(17)30705-3
  89. 89. Abakpa GO, Umoh VJ, Ameh JB, et al. Diversity and antimicrobial resistance of Salmonella enterica isolated from fresh produce and environmental samples. Environmental Nanotechnology, Monitor Management. 2015;3:38-46
  90. 90. Marin C, Martín-Maldonado B, Cerdà-Cuéllar M, et al. Antimicrobial resistant Salmonella in chelonians: Assessing its potential risk in zoological institutions in Spain. Veterinary Science. 2022;9. DOI: 10.3390/VETSCI9060264
  91. 91. Simpson KMJ, Mor SM, Ward MP, et al. Genomic characterisation of Salmonella enterica serovar Wangata isolates obtained from different sources reveals low genomic diversity. PLoS One. 2020;15:e0229697
  92. 92. Hermans APHM, Beuling AM, van Hoek AHAM, et al. Distribution of prophages and SGI-1 antibiotic-resistance genes among different Salmonella enterica serovar Typhimurium isolates. Microbiology. 2006;152:2137-2147
  93. 93. de Jong HK, Parry CM, van der Poll T, et al. Host-pathogen interaction in invasive salmonellosis. PLoS Pathogens. 2012. DOI: 10.1371/journal.ppat.1002933
  94. 94. Harish B, Menezes G. Antimicrobial resistance in typhoidal Salmonellae. Indian Journal of Medical Microbiology. 2011. DOI: 10.4103/0255-0857.83904
  95. 95. Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: Tracking the trend in Nigeria. The American Journal of Tropical Medicine and Hygiene. 2018. DOI: 10.4269/ajtmh.18-0045
  96. 96. Kasper MR, Sokhal B, Blair PJ, et al. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia. Diagnostic Microbiology and Infectious Disease. 2010;66:207-209
  97. 97. Britto CD, Wong VK, Dougan G, et al. A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. PLoS Neglected Tropical Diseases. 2018;12:e0006779
  98. 98. Mastrorilli E, Petrin S, Orsini M, et al. Comparative genomic analysis reveals high intra-serovar plasticity within Salmonella napoli isolated in 2005-2017. BMC Genomics. 2020;21:1-16
  99. 99. Kariuki S, Onsare RS. Epidemiology and genomics of invasive nontyphoidal Salmonella infections in Kenya. Clinical Infectious Diseases. 2015;61:S317-S324
  100. 100. Marin C, Lorenzo-Rebenaque L, Laso O, et al. Pet reptiles: A potential source of transmission of multidrug-resistant Salmonella. Frontiers in Veterinary Science. 2021;7:1157
  101. 101. Zorgani A, Ziglam H. Typhoid fever: Misuse of Widal test in Libya. Journal of Infection in Developing Countries. 2014;8:680-687
  102. 102. Castonguay-Vanier J, Davong V, Bouthasavong L, et al. Evaluation of a simple blood culture amplification and antigen detection method for diagnosis of Salmonella enterica serovar Typhi bacteremia. Journal of Clinical Microbiology. 2013;51:142-148
  103. 103. MacFadden DR, Bogoch II, Andrews JR. Advances in diagnosis, treatment, and prevention of invasive Salmonella infections. Current Opinion in Infectious Diseases. 2016;29:453-458
  104. 104. Odeyemi OA. Bacteriological safety of packaged drinking water sold in Nigeria: Public health implications. Springerplus. 2015. DOI: 10.1186/s40064-015-1447-z
  105. 105. Gunn JS, Marshall JM, Baker S, et al. Salmonella chronic carriage: Epidemiology, diagnosis, and gallbladder persistence. Trends in Microbiology. 2014;22:648-655
  106. 106. Saporito L, Colomba C, Titone L. Typhoid fever. In: International Encyclopedia of Public Health. London, UK: Oxford Press; 2016
  107. 107. Scott S. Bailey and Scott’s Diagnostic Microbiology. Amsterdam, The Netherlands: Elsevier; 2014
  108. 108. Malehmir S, Ranjbar R, Harzandi N. The molecular study of antibiotic resistance to quinolones in Salmonella enterica strains isolated in Tehran, Iran. Open Microbiology Journal. 2017;11:189-194
  109. 109. Clinical Laboratory Standard Institue (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI Supplement M100S. Wayne, USA: CLSI; 2018
  110. 110. Chen S, Zhao S, White DG, et al. Characterization of Salmonella serovars isolated from retail meats. Applied and Environmental Microbiology. 2004;70:1-7
  111. 111. Hur J, Jawale C, Lee JH. Antimicrobial resistance of Salmonella isolated from food animals: A review. Food Research International. 2012;45:819-830
  112. 112. Kaprou GD, Papadakis G, Papageorgiou DP, et al. Miniaturized devices for isothermal DNA amplification addressing DNA diagnostics. Microsystem Technologies. 2016;22:1529-1534
  113. 113. Mayboroda O, Katakis I, O’Sullivan CK. Multiplexed isothermal nucleic acid amplification. Analytical Biochemistry. 2018;545:20-30
  114. 114. Tanner NA, Zhang Y, Evans TC. Visual detection of isothermal nucleic acid amplification using pH-sensitive dyes. BioTechniques. 2015;58:59-68
  115. 115. CDC. Serotypes and the importance of serotyping Salmonella, Salmonella atlas, reports and publications, Salmonella, CDC. Centers for Disease Control Prevention. 2015. DOI: 10.1208/s12249-010-9573-y
  116. 116. Mercer R, Nguyen O, Ou Q , et al. Functional analysis of genes encoded by the locus of heat resistance in Escherichia coli. Applied and Environmental Microbiology. 2017. DOI: 10.1128/AEM.01400-17
  117. 117. Ammar AM, Mohamed AA, El-Hamid MIA, et al. Virulence genotypes of clinical Salmonella serovars from broilers in Egypt. Journal of Infection in Developing Countries. 2016. DOI: 10.3855/jidc.7437
  118. 118. Cajetan ICI, Bassey BE, Florence IN, et al. Prevalence and antimicrobial susceptibility of Salmonella species associated with childhood acute gastroenteritis in Federal Capital Territory Abuja, Nigeria. British Microbiology Research Journal. 2013;3:431-439
  119. 119. Karmi M. Detection of virulence gene (inva) in Salmonella isolated from meat and poultry products. International Journal of Genetics. 2013;3:7-12
  120. 120. Crump JA, Heyderman RS. A perspective on invasive Salmonelladisease in Africa. Clinical Infectious Diseases. 2015;61:S235-S240
  121. 121. Weile J, Knabbe C. Current applications and future trends of molecular diagnostics in clinical bacteriology. Analytical and Bioanalytical Chemistry. 2009;394:731-742
  122. 122. Capuano F, Mancusi A, Capparelli R, et al. Characterization of drug resistance and virulotypes of Salmonella strains isolated from food and humans. Foodborne Pathogens and Disease. 2013;10:963-968
  123. 123. Parry CM. Antimicrobial drug resistance in Salmonella enterica. Current Opinion in Infectious Diseases. 2003;16:467-472
  124. 124. Tennant SM, Toema D, Qamar F, et al. Detection of typhoidal and paratyphoidal Salmonella in blood by real-time polymerase chain reaction. Clinical Infectious Diseases. 2015;61:S241-S250
  125. 125. Aworh MK, Kwaga JKP, Hendriksen RS, et al. Genetic relatedness of multidrug resistant Escherichia coli isolated from humans, chickens and poultry environments. Antimicrobial Resistance and Infection Control. 2021;10:1-13
  126. 126. Messens W, Hugas M, Afonso A, et al. Advancing biological hazards risk assessment. EFSA Journal. 2019;17. DOI: 10.2903/j.efsa.2019.e170714
  127. 127. Bernreiter-hofer T, Schwarz L, Müller E, et al. The pheno- and genotypic characterization of porcine escherichia coli isolates. Microorganisms. 2021;9:1-21
  128. 128. Crump JA, Wain J. Salmonella. In: International Encyclopedia of Public Health. 2016
  129. 129. Opintan JA, Newman MJ, Arhin RE, et al. Laboratory-based nationwide surveillance of antimicrobial resistance in Ghana. Infection and Drug Resistance. 2015;8:379-389
  130. 130. Algammal AM, Hetta HF, Batiha GE, et al. Virulence-determinants and antibiotic-resistance genes of MDR-E. coli isolated from secondary infections following FMD-outbreak in cattle. Scientific Reports. 2020;10. DOI: 10.1038/S41598-020-75914-9
  131. 131. Ifeanyi SS. Molecular detection of some virulence genes in Salmonella spp. isolated from food samples in Lagos, Nigeria. Animal Veterinary Science. 2015. DOI: 10.11648/j.avs.20150301.15
  132. 132. Zankari E, Hasman H, Cosentino S, et al. Identification of acquired antimicrobial resistance genes. The Journal of Antimicrobial Chemotherapy. 2012. DOI: 10.1093/jac/dks261
  133. 133. Hamid N, Jain SK. Characterization of an outer membrane protein of Salmonella enterica serovar Typhimurium that confers protection against typhoid. Clinical and Vaccine Immunology. 2008. DOI: 10.1128/CVI.00093-08
  134. 134. Langendorf C, Le Hello S, Moumouni A, et al. Enteric bacterial pathogens in children with diarrhea in Niger: Diversity and antimicrobial resistance. PLoS One. 2015;10. DOI: 10.1371/journal.pone.0120275
  135. 135. Mandomando I, Bassat Q , Sigaúque B, et al. Invasive Salmonella infections among children from rural Mozambique, 2001-2014. Clinical Infectious Diseases. 2015;61:S339-S345
  136. 136. Fagbamila IO, Mancin M, Barco L, et al. Investigation of potential risk factors associated with Salmonella presence in commercial laying hen farms in Nigeria. Preventive Veterinary Medicine. 2018. DOI: 10.1016/j.prevetmed.2018.02.001
  137. 137. Haselbeck AH, Panzner U, Im J, et al. Current perspectives on invasive nontyphoidal Salmonella disease. Current Opinion in Infectious Diseases. 2017;30:498-503
  138. 138. Morpeth SC, Ramadhani HO, John AC. Invasive non-Typhi Salmonella disease in Africa. Clinical Infectious Diseases. 2009;49:606-611
  139. 139. Pui CF, Wong WC, Chai LC, et al. Salmonella: A foodborne pathogen. International Food Research Journal. 2011;10:18
  140. 140. Sánchez-Vargas FM, Abu-El-Haija MA, Gómez-Duarte OG. Salmonella infections: An update on epidemiology, management, and prevention. Travel Medicine and Infectious Disease. 2011;9:263-277
  141. 141. United States Department of Agriculture. Generic HACCP Model for Poultry Slaughter. HACCP-5; Washington DC, USA: Department of Agriculture; 1999. pp. 1-35
  142. 142. Northcutt JK, Russell SM. General guidelines for implementation of HACCP in a poultry processing plant. College of Agricultural and Environmental Journal. 2010;3:1-8
  143. 143. Hamrin P, Hoeft B. Quality control throughout the production process of infant food. Annals of Nutrition & Metabolism. 2012;60:208-210
  144. 144. Okonko IO, Adejoye OD, Ogun a a et al. Hazards Analysis Critical Control Points (HACCP) and Microbiology Qualities of Sea-Foods as Affected by Handler’ s Hygience in Ibadan and Lagos vol. 3. Nigeria; Onward press; 2009. PP. 35-50
  145. 145. Henry CJK, Xin JLW. Application of hazard analysis critical control point in the local manufacture of ready-to-use therapeutic foods (RUTFs). Food and Nutrition Bulletin. 2014;35:S57-S63

Written By

Leonard I. Uzairue and Olufunke B. Shittu

Submitted: 08 July 2022 Reviewed: 29 November 2022 Published: 19 January 2023